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Abstract
Isoprenoids, which are a large group of natural and chemical compounds with a variety of applications as e.g. fragrances,
pharmaceuticals and potential biofuels, are produced via two different metabolic pathways, the mevalonate (MVA) pathway
and the 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway. Here, we attempted to replace the endogenous MVA pathway
in Saccharomyces cerevisiae by a synthetic bacterial MEP pathway integrated into the genome to benefit from its superior
properties in terms of energy consumption and productivity at defined growth conditions. It was shown that the growth of
a MVA pathway deficient S. cerevisiae strain could not be restored by the heterologous MEP pathway even when
accompanied by the co-expression of genes erpA, hISCA1 and CpIscA involved in the Fe-S trafficking routes leading to
maturation of IspG and IspH and E. coli genes fldA and fpr encoding flavodoxin and flavodoxin reductase believed to be
responsible for electron transfer to IspG and IspH.
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Introduction
In connection with the production of many natural products the
transfer of complete biosynthetic pathways from native to
heterologous organisms is an attractive approach, as it may allow
for use of industrially compatible strains and for further pathway
engineering [1,2,3]. Although this approach imposes a number of
challenges such as gene codon optimization, correct protein
folding and proper enzyme function, there are a several examples
where whole biochemical pathways have been transferred
successfully such as expressing the mevalonate (MVA) pathway
in Escherichia coli [4], transferring a complex mammalian hydro-
cortisone biosynthetic pathway containing 8 genes into yeast [5],
and re-construction of the early four steps of the flavonoid
biosynthetic pathway in Saccharomyces cerevisiae in order to convert
phenylpropanoid acids into flavanones [6].
The MVA pathway in yeast and most other eukaryotes and the
2-C-methyl-D-erythritol (MEP) pathway in most bacteria and
plant plastids are responsible for production of isoprenoids, which
represent an important class of biochemical compounds [7]. The
MEP pathway was first reported independently by Rohmer and
Argoni [8,9]. This pathway initiates by condensation of one
molecule each of pyruvate and D-glyceralaldehyde-3-phosphate
through a thiamin diphosphate dependent reaction catalyzed by 1-
deoxy-D-xylulose 5-phosphate synthase (Dxs) [10], followed by an
NADPH dependent reduction process being catalyzed by 1-deoxy-
D-xylulose 5-phosphate reductoisomerase (Dxr) [11], generating
2-C-methyl-D-erythritol 4-phosphate (MEP). This intermediate is
converted into the cyclic 2,4-diphosphate of 2-C-methyl-D-
erythritol by the sequential action of the enzymes specified by
IspD, IspE and IspF [12,13,14]. 2-C-methyl-D-erythritol-2,4-
cyclodiphosphate is reduced by a reductase encoded by the ispG
gene [15,16] followed by the production of IPP and DMAPP by
the action of the ispH gene product [17,18]. Unlike the MVA
pathway, the MEP pathway has not been investigated extensively,
in particular in heterologous hosts. S. cerevisiae is widely used as a
platform for heterologous expression of biochemical pathways
[5,19,20], due to its well-characterized physiology and the
availability of molecular biology tools. Maury and co-workers
reported the reconstruction of the bacterial MEP pathway in S.
cerevisiae by expression of seven enzymatic steps of the pathway
from self-replicating, high-copy yeast plasmids [21]. By inhibiting
the endogenous MVA pathway through addition of lovastatin, it
was shown that the MEP pathway was active and could ensure
production of ergosterol, which is essential for yeast. However,
transferring entire biochemical pathways using episomal plasmids
is not recommended for industrial applications due to poor genetic
stability. In addition, maintenance of plasmids requires selective
pressure provided by selective media which increase the costs. In
contrast, gene integration offers a stable manipulation without
requirement of selective pressure provided through the media.
In this work, we show by using genome-scale modeling that
transferring the entire bacterial MEP pathway into S. cerevisiae gives
a higher theoretical maximum yield of the isoprenoid precursor
compared with biosynthesis via the endogenous MVA pathway. In
order to activate this pathway in yeast eight enzymatic steps of the
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bacterial MEP pathway were integrated into the chromosome of S.
cerevisiae. Following expression of the heterologous MEP pathway,
we found that the IspG and the IspH enzymes are potential
bottlenecks of the MEP pathway in S. cerevisiae and activating them
requires the successful transfer of Fe-S clusters to these two
enzymes and a suitable electron transfer system. Therefore, both
possible Fe-S trafficking routes responsible for maturation of IspG
and IspH and a bacterial electron transfer system were re-
constructed in the yeast cytosol by co-expression of the bacterial
gene erpA with iscA from either human or Arabidopsis thaliana and
flavodoxin and flavodoxin reductase, respectively. These genetic
modifications were accompanied with over-expression of IspG and
IspH from A. thaliana. However, introducing the above mentioned
manipulations did not result in a functional MEP pathway in S.
cerevisiae.
Based on this study we suggest that specific physical interaction
or compartmentalization is required for in vivo biogenesis and
transfer of essential prosthetic groups, in this case transfer of iron-
sulfur clusters, into apoIspG and apoIspH and consequently
activation of the bacterial MEP pathway.
Results
In silico Evaluation of MVA and MEP Pathway in S.
cerevisiae
Seven genes responsible for the enzymatic steps of the bacterial
MEP pathway (Figure 1) were introduced into the yeast genome
scale metabolic model iIN800 [22]. The efficiency of the MEP
pathway was evaluated and compared with the endogenous MVA
pathway using the model. The model was optimized for maximum
production of farnesyl pyrophosphate (FPP), which is a branch
point intermediate in ergosterol biosynthesis, for two different
conditions, using the endogenous MVA pathway and using the
heterologous MEP pathway, respectively. The result showed that
by consuming 1 mol of glucose 0.21 and 0.24 mol farnesyl
pyrophosphate could be produced through the MVA and MEP
pathway, respectively. According to this analysis the FPP
production through the MEP pathway results in a favorable
theoretical yield.
The stoichiometry calculation of NAD(P)H and ATP consump-
tion for both pathways showed that for producing one molecule of
farnesyl pyrophosphate from glucose via the MVA pathway six
molecules of NADPH and nine molecules of ATP are required,
while production via the MEP pathway consumes nine molecules
of NAD(P)H and six molecules of ATP. Provision of sufficient
cytosolic NADPH is therefore a critical factor for both pathways.
In contrast to the MEP pathway, which consumes only 3
molecules of glucose, the MVA pathway consumes 4.5 molecules
of glucose for the biosynthesis of one molecule farnesyl pyrophos-
phate (these values are excluding use of glucose for production of
ATP and redox co-factors).
Combining the results derived from the yeast genome scale
metabolic model and the stoichiometry calculation, it became
evident that the MEP pathway is a more efficient route than the
endogenous MVA pathway for isoprenoid production in terms of
energy consumption and productivity. Therefore we decided to
investigate this pathway in S. cerevisiae, which has been widely used
as a platform for heterologous expression of isoprenoids [19,20].
Genomic Integration of MEP Pathway Genes
Since the efficiency of in vivo homologous recombination in S.
cerevisiae is high, a bipartite integration strategy was applied [23].
Eight codon optimized MEP pathway genes including dxs, dxr,
ispD, ispE, ispF, ispG, ispH and idi were organized in four different
synthetic fragments (Figure 2A). Each fragment contained two
genes located on each side of the bidirectional promoter PTEF1-
PPGK1, which had shown high constitutive activity in glucose
containing media before [24], and in front of either the ADH1 or
the CYC1 terminator. Furthermore, each fragment harbored a
part (ca. 2/3) of a gene coding for a selectable marker (kanMX or
K.l.URA3) and flanking regions which corresponded to the desired
integration site on the chromosome and which were necessary for
integration via homologous recombination. In order to recycle the
selectable markers, direct repeat DNA sequences of 143 bp were
introduced at both sides of K.l.URA3, whereas loxP sites flanked the
kanMX cassette.
Previously, different transcription levels among various chro-
mosomal regions in S. cerevisiae have been reported by using lacZ as
a reporter gene [25]. We have shown that the two integration sites,
YPRCD15 and YPRCt3, on chromosome XVI of S. cerevisiae
provided potentially higher expression levels than other regions
tested [25]. Therefore, all genes involved in the bacterial MEP
pathway were integrated into these two sites in two steps
(Figure 2A). The selectable markers, kanMX and K.l.URA3, were
looped out. Integration and transcription of the MEP genes was
confirmed by PCR and RT-PCR, respectively (data not shown).
Table 1 lists the strains which were constructed during this work.
Strains SCISP06 and SCISP12 were obtained through the
integration of MEP pathway genes into the chromosome of
CEN.PK 113-13D and CEN.PK 113-1C, respectively.
The functionality of the bacterial MEP pathway was tested by
blocking the endogenous MVA pathway which is essential for S.
cerevisiae because of its supply of ergosterol involved in regulation of
membrane fluidity [26]. The MVA pathway was inhibited using
lovastatin (mevinolin) [27] which is a therapeutic agent and acts as
a competitive inhibitor of an early pathway enzyme, HMG-CoA
reductase. Surprisingly, no growth was observed in both wild type
(CEN.PK 113-13D) and SCISP06 (yeast strain with integrated
MEP pathway) in presence of 2 g L21 lovastatin (Figure 3),
respectively, which showed that the MEP pathway could not
complement the MVA pathway, and which is in contrast to the
previous report [21].
Re-construction the Possible Bacterial Fe/S Trafficking
Routes and the Bacterial Electron Transfer System
The detection of intermediates 3 and 5 (Figure 1) in the MEP-
pathway carrying yeast strains indicated proper activity of the Dxs,
Dxr and the IspD enzymes (data not shown). In addition, no-
activity was observed for the last two enzymes of the MEP
pathway, IspG and IspH, when expressed in yeast in a previous
study [28]. IspG and IspH are known to be iron-sulfur cluster
proteins [15,16,17,29,30,31] and it has been reported that this
cluster is directly involved in IspH activity [32]. The essential role
of ErpA, which is an A-type iron-sulfur cluster protein, in the
maturation process of IspG, and probably IspH, in E. coli has been
investigated [33]. Furthermore, Puan and co-workers [34]
identified fldA as an essential gene for isoprenoid biosynthesis in
E. coli, as it provides reducing equivalents for the Fe/S clusters of
IspG and IspH. FldA encodes flavodoxin I, which together with fpr
encoded flavodoxin reductase composes an E. coli electron transfer
system [35]. As an attempt to solve the problem of the non-
functionality of the MEP pathway in S. cerevisiae, the impact of the
co-expression of genes involved in transferring Fe-S clusters to
IspG/IspH apoproteins and of the described E. coli electron
transfer system was investigated. The coding region of genes erpA,
fpr and fldA from E. coli were cloned on a single plasmid, pISP08,
(Figure 2B) that was transformed into SCISP06 generating
SCISP16 (Table1). The empty plasmid pSP-GM1 was trans-
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Figure 1. The MEP pathway (left). Enzymes: Dxs, 1-deoxy-D-xylulose-5-phosphate synthase; Dxr, 1-deoxy-D-xylulose 5-phosphate
reductoisomerase; IspD, 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase; IspE, 4-diphosphocytidyl-2-C-methylerythritol kinase; IspF, 2-C-
methyl-D-erythritol 2,4-cyclodiphosphate synthase; IspG, 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase; IspH, 1-hydroxy-2-methyl-butenyl
4-diphosphate reductase; Metabolites: 1, D-glyceraldehyde 3-phosphate; 2, pyruvate; 3, 1-deoxy-D-xylulose 5-phosphate; 4, 2-C-methyl-D-erythritol
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formed into CEN.PK113-13D and SCISP06 resulting in SCISP28
and SCISP29, respectively (Table 1).
To rule out any possible additional effect on cell growth using
lovastatin for inhibition of the MVA pathway the functionality of
the bacterial MEP pathway was investigated by deletion of ERG13,
an essential gene in the MVA pathway. ERG13 encodes HMG-
CoA synthase [7], and its disruption results in a strain that requires
exogenous mevalonate supplementation for viability [36]. The
coding region of ERG13 in strains SCISP16, SCISP28 and
SCISP29 was replaced by a kanMX integration cassette, which was
confirmed by PCR (Figure 4A). As it is illustrated in Figure 4B, the
ERG13 deleted strains could not grow in media lacking
mevalonate under aerobic conditions.
Since bacterial IspG and IspH have not shown any activity in
yeast [28], we asked whether a eukaryotic version of both IspG
and IspH would be active in yeast; the codon optimized plant
4-phosphate; 5, 4-diphosphocytidyl-2-C-methyl-D-erythritol; 6, 2-phospho-4-diphosphocytidyl-2-C-methyl-D-erythritol; 7, 2-C-methyl-D-erythritol
2,4-cyclodiphosphate; 8, 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate. The MVA pathway (right). Enzymes: Erg10, acetoacetyl-CoA thiolase;
Erg13, 3-hydroxy-3-methylglutaryl-CoA synthase; Hmg1/2, 3-hydroxy-3-methylglutaryl-CoA reductase; Erg12, mevalonate kinase; Erg8,
phosphomevalonate kinase; Erg19, mevalonate diphosphate decarboxylase; Idi, isopentenyl diphosphate isomerase; Metabolites: 9, acetyl-CoA;
10, acetoacetyl-CoA; 11, 3-hydroxy-3-methylglutaryl-CoA; 12, mevalonate; 13, phosphomevalonate; 14, diphosphomevalonate; 15, isopentenyl
diphosphate; 16, dimethyl allyl diphosphate.
doi:10.1371/journal.pone.0052498.g001
Figure 2. Schematic representation of genetic engineering strategies for A) genomic integration of the bacterial MEP pathway
genes into the yeast genome (chromosome XVI), and B) plasmid-based reconstruction of possible Fe/S trafficking routes involved
in maturation of bacterial IspG/IspH, bacterial electron transfer systems and plant-derived ispG/ispH in S. cerevisiae. For details see
text.
doi:10.1371/journal.pone.0052498.g002
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genes of IspG and IspH from A. thaliana were chemically
synthesized. In addition, an Fe-S trafficking model has previously
been proposed that describes the transfer of Fe-S clusters to IspG
and IspH in E. coli (Figure 5) [37]. The authors suggested that
depending on the environmental conditions e.g. aerobic, anaer-
obic or stress, the Fe-S cluster is transferred from IscU or SufU
scaffolds to apoIspG and apoIspH through the combination of A-
type carriers including ErpA, IscA and SufA [37]. Assuming that
this model can be transferred from E. coli to yeast the expression of
iscA may fill the gap in this proposed model [37]. Therefore, one
copy of each IspG and IspH from A. thaliana was cloned into
expression plasmids with iscA from either human or A. thaliana
resulting in pISP24 and pISP25, respectively (Figure 2B). Previ-
ously, localization and activity of human ISCA1 (hISCA1) was
shown in mitochondria as well as in the cytosol of HeLa cells [38].
The authors have also demonstrated interaction of the small
Table 1. List of strains and plasmids used in this study.
Strain Genotype Plasmid Reference
CEN.PK 113-13D MATa MAL2-8c SUC2 ura3-52 None P. Ko¨tter1
SCISP06 MATa MAL2-8c SUC2 ura3-52 dxs dxr ispD ispE ispF
ispG ispH idi
None this work
SCISP16 MATa MAL2-8c SUC erg13::loxP-KanMX-loxP dxs dxr ispD
ispE ispF ispG ispH idi
pISP08 this work
SCISP28 MATa MAL2-8c SUC2 erg13::loxP-KanMX-loxP, pSP-GM1 this work
SCISP29 MATa MAL2-8c SUC2 erg13::loxP-KanMX-loxP dxs dxr
ispD ispE ispF ispG ispH idi
pSP-GM1 this work
CEN.PK 113-1C MATa MAL2-8c SUC2 trp1-289 ura3-52 his3D1 None P. Ko¨tter1
SCISP12 MATa MAL2-8c SUC2 trp1-289 ura3-52 his3D1 dxs dxr
ispD ispE ispF ispG ispH idi
None this work
SCISP13 MATa MAL2-8c SUC2 trp1-289 his3D1 dxs dxr ispD ispE ispF ispG ispH idi pISP082 this work
SCISP30 MATa MAL2-8c SUC2 trp1-289 erg13::loxP-KanMX-loxP pSP-GM1, pSP-GM3 this work
SCISP31 MATa MAL2-8c SUC2 trp1-289 erg13::loxP-KanMX-loxP
dxs dxr ispD ispE ispF ispG ispH idi
pISP08, pISP243 this work
SCISP32 MATa MAL2-8c SUC2 trp1-289 erg13::loxP-KanMX-loxPdxs
dxr ispD ispE ispF ispG ispH idi
pISP08, pISP254 this work
1University of Frankfurt, Germany.
2pISP08 contains erpA, fpr and fldA.
3pISP24 contains hISCA1, At-IspG and At-IspH.
4pISP25 contains CpIscA, At-IspG and At-IspH.
doi:10.1371/journal.pone.0052498.t001
Figure 3. Growth of S. cerevisiae strains CEN.PK 113-13D (black circles) and SCISP06 (gray circles) in SD minimal medium. Dashed
lines represent the growth in 0 g L21 of lovastatin; solid lines represent the growth in presence of 2 g L21 of lovastatin. Error bars show the standard
deviation from three cultivations.
doi:10.1371/journal.pone.0052498.g003
The MEP Pathway in Saccharomyces cerevisiae
PLOS ONE | www.plosone.org 5 December 2012 | Volume 7 | Issue 12 | e52498
The MEP Pathway in Saccharomyces cerevisiae
PLOS ONE | www.plosone.org 6 December 2012 | Volume 7 | Issue 12 | e52498
domain of IOP1 (Iron-only hydrogenase-like protein I) with
human ISCA1 using yeast two-hybrid systems [38]. CpIscA from
A. thaliana is involved in Fe-S biogenesis in chloroplasts [39]. The
Fe-S cluster in CpIspA indicated stability in presence of oxygen
[39]. Strains SCISP31 and SCISP32 were constructed by co-
transforming pISP08 with either pISP24 or pISP25 into SCISP12,
respectively (Table 1). Like for SCISP16, no growth was observed
in the absence of exogenous mevalonate when ERG13 was
disrupted in both SCISP31 and SCISP32 (Figure 4C).
Fe-S clusters are sensitive to superoxide (O2
2) and other
oxidative agents [40,41]. In addition, the Fe-S cluster of IspH is
easily destroyed by exposure to molecular oxygen or other
oxidative agents [32]. Therefore, to prevent inactivation of the
Fe-S clusters in IspG and IspH, all erg13 strains were also evaluated
under anaerobic conditions. Yeast growing in anaerobic condition
is ergosterol-dependent as the biosynthetis of ergosterol is
disrupted in this condition. Therefore, exogenous ergosterol was
added to the SD media at a final concentration of 1 mg L21.
None of the erg13 strains showed mevalonate-independent growth
(Figure 4D and 4E). This means that even in anaerobic conditions,
the MEP pathway was not able to complement the MVA pathway.
Discussion
In the current study, the seven enzymatic reactions of the
bacterial MEP pathway were evaluated in silico, using the yeast
genome scale metabolic model, iIN800 [22]. iIN800 consists of
1446 metabolic reactions and 1013 metabolites [22]. In compar-
ison to the first S. cerevisiae model by Fo¨rster and co-workers [42],
iIN800 covers lipid metabolism in great detail. Applying
mathematical models has previously been demonstrated to be
predictive and beneficial for metabolic engineering approaches
e.g. to identify new target genes enhancing the biosynthesis of
sesquiterpenes in yeast [43], and to schematically represent the
effect of the interaction of protease supplementation and type of
sugar on amino acid metabolisms in brewer’s yeast [44]. Here, in
silico analysis of the bacterial MEP pathway expressed in yeast
revealed the benefits of this heterologous pathway in terms of
energy consumption and yield compared to the endogenous MVA
pathway. Our result is in consistence with previous reports about
the higher efficiency of the MEP pathway in converting sugars or
glycerol into terpenoids compared to the MVA pathway [45,46].
This is the rationale for our attempt to express the bacterial MEP
pathway in yeast for production of isoprenoids.
The first step of most yeast metabolic engineering and synthetic
biology studies involves re-construction of a complete or partially
synthetic pathway. Although several methods have been developed
[3,47], in vitro DNA synthesis offers a fast, cheap and efficient
method for synthesis of large DNA sequences [48,49]. Besides,
using synthetic genes with the possibility to manipulate codon bias
can provide better control of the expression of heterologous MEP
pathway genes in yeast. From the genetic engineering point of
view, the codon bias is one of the first barriers in heterologous
protein expression [50] and it can prevent the efficient biosynthesis
of a recombinant protein because of altering the correlation
between the frequency of the codon and the abundance of its
corresponding tRNA, which impairs the translation machinery of
the host [51]. The high efficiency and ease to work with in vivo
homologous recombination in S. cerevisiae allows stable manipula-
tion without requiring selective pressure for maintenance. Here we
developed a strategy for easy integration of eight heterologous
genes. The four DNA constructs containing the eight MEP
pathway genes, including expression elements and selection
markers were designed in silico, synthesized in vitro and integrated
into the yeast chromosome via homologous recombination. The
functionality of this pathway in S. cerevisiae was evaluated by the
attempt to block the endogenous MVA pathway. Inhibition of the
MVA pathway can be achieved using an inhibitor or by deletion of
the essential genes of this pathway [26,36,52–55]. Unlike
previously reported [21], chemical as well as genetic inhibition
of MVA pathway revealed the non-functionality of the MEP
pathway. We conclude that the previous result [21] may have
derived from incomplete repression of the MVA pathway, even
when higher concentrations (2 g L21) of lovastatin were used,
which may result from errors in activation of lovastatin by
hydrolysis reducing the actual concentration of the active
inhibitor, or the higher-level expression from multi-copy plasmids
may have resulted in partial activation of the enzymes resulting in
a functional MEP pathway. One could speculate that elevation of
the number of mitochondria using galactose as a non-fermentable
carbon source in the previous report [21] might have led to the
functional MEP pathway. In eukaryotes, these organelles play a
central role in maturation of Fe/S proteins in both mitochondria
and cytosol. However, the strains presented in our work did not
grow in media containing raffinose when the MVA pathway was
inhibited using lovastatin (data not shown), and this strongly
indicate that our previous claim of an active MEP pathway in
yeast was based on lack of proper repression of the MVA pathway
as also found in another study [28].
High concentrations of lovastatin could also have caused side
effects which mask the operation of the MEP pathway. Thus, the
inhibition of Hmg1 and Hmg2 using lovastatin has shown to result
in an altered transcriptional response including the up-regulation
of genes related to plasma membrane proteins, protein catabolism
and ribosome biosynthesis and down-regulation of MAF1 [56,57]
which encodes a repressor of RNA polymerase III [58]. Priviously,
Kaminska and co-workers have shown an increase in tRNA levels
when Maf1 is diminished [59] and consequently the demand for
DMAPP, which is involved in tRNA biosynthesis, was increased
[60]. Such requirement may be higher than what is provided by
the MEP pathway. Gene deletion in contrast offers absolute
inactivation of the MVA pathway. It has been indicated that yeast
strains with deficiency in ERG13, ERG19, ERG8, or ERG9 are
nonviable at normal growth conditions [26,36,52–55]. Since the
MEP pathway contributes to the ergosterol biosynthetic pathway
through IPP and DMAPP intermediates, deletion of ERG13,
ERG19 or ERG8 which are located upstream of these intermedi-
ates should be more efficient than using lovastatin for blocking the
MVA pathway and evaluating the MEP pathway functionality.
For our purpose ERG13 is a good candidate since supplying the
medium with exogenous mevalonate can complement its deletion.
However, the inability of the ERG13 deleted strain to grow showed
Figure 4. Schematic representation of evaluation the functionality of the bacterial MEP pathway in S. cerevisiae in different
conditions. A) Gel electrophoresis of PCR products to confirm deletion of ERG13 (1: SCISP28, 2: SCISP29, 3: SCISP16, 4: CEN.PK 113-13D (wild type), 5:
SCISP30, 6: SCISP31, 7: SCISP32, M: 1 kb Plus DNA ladder (Fermentas, Maryland, USA); B) Aerobic cultivation of MEP pathway strains co-expressing
erpA, fpr and fldA; C) Aerobic cultivation of MEP pathway strains co-expressing erpA, fpr, fldA, At-IspG, At-IspH with either CpIscA or hISCA1; D)
Anaerobic cultivation of MEP pathway strains co-expressing erpA, fpr and fldA; E) Anaerobic cultivation of MEP pathway strains co-expressing erpA,
fpr, fldA, At-IspG, At-IspH with either CpIscA or hISCA1. All strains carried an ERG13 deletion and were plated on medium with or without 10 mg L21
mevalonate (MVA).
doi:10.1371/journal.pone.0052498.g004
The MEP Pathway in Saccharomyces cerevisiae
PLOS ONE | www.plosone.org 7 December 2012 | Volume 7 | Issue 12 | e52498
that the MEP pathway could not complement the MVA pathway
deficiency.
We hypothesize that a potential reason for the non-functionality
of the MEP pathway in S. cerevisiae is the lack of the enzyme activity
of IspG and/or IspH, which catalyze the last two reactions of the
pathway. It has been reported that both enzymes, IspG and IspH,
are dependent on NADPH and the flavodoxin/flavodoxin
reductase redox system as electron donor for their catalytic
activity [17,18,34,61–63]. Gra¨wert and co-workers [32] have
reported that the in vitro maximum activity for IspH was obtained
with NADPH as co-substrate, together with recombinant
flavodoxin and flavodoxin reductase from E. coli. Flavodoxin and
flavodoxin reductase are FMN and FAD cofactor containing
proteins, respectively, and it has been shown that NADPH is the
preferred reducing equivalent of flavodoxin reductase compared to
NADH [35]. Overexpression of flavodoxin and flavodoxin
reductase might facilitate electron flux from NADPH to IspG
and IspH and therefore result in increased the activity of these
enzymes. A similar phenomenon was observed in biosynthesis of
hydrocortisone in yeast [5]. Overexpression of the essential
endogenous reductase Arh1 (adrenodoxin eeductase homolog)
using a strong promoter increased the production of hydrocorti-
sone up to 60% [5]. Both Arh1 and human ADX protein
(adrenodoxin) are responsible for transferring electrons from
NADPH to the related enzyme. The authors suggested that the
flux of electrons was elevated as a result of ARH1 overexpression
[5]. Furthermore, both IspG and IspH are known as iron-sulfur
cluster proteins which are harboring cubic type of Fe/S clusters,
and it has been suggested that these [4Fe–4S] clusters participate
in the electron transfer process [15–17,29–31]. Despite the
Figure 5. Schematic representation of possible Fe/S trafficking routes involved in maturation of bacterial IspG/IspH in E. coli (left)
and reconstruction of possible routes preformed in this study in the yeast cytosol (right). Dashed arrows represent unknown
mechanisms for transferring the Fe-S clusters from mitochondria to cytosol. For more information see text.
doi:10.1371/journal.pone.0052498.g005
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presence of Fe-S assembly machineries in yeast - the ISC system is
present in the mitochondria and the CIA system is used for
cytosolic FeS cluster assembly [64–66] - these systems may not be
suitable to transfer iron-sulfur clusters to IspG and IspH. Recently,
a suitable model has been proposed demonstrating the Fe/S
trafficking paths leading to IspG and IspH maturation in E. coli
[37]. The essential role of ErpA in maturation of the IspG and the
IspH enzymes in E. coli has been indicated [33]. It was also shown
that the Fe-S clusters can directly be transferred from IscU to
ErpA in E. coli [67]. Based on these findings, the functionality of
the bacterial MEP pathway was evaluated in presence of the
cytosolic expression of bacterial genes erpA, fpr and fldA in yeast,
but we still could not obtain functionality of the enzymes.
Previously reported data have shown that the cytosolic localization
has failed to generate a functional bacterial or human IscU while
expressed in yeast [68]. Even yeast U-type homolog scaffolds (Isu1
and Isu2) playing a crucial role in maturation of both cytosolic and
mitochondrial Fe-S proteins need to be expressed in mitochondria
to show activity [68].
As illustrated in Figure 5, the Fe-S cluster is transferred to the
last two enzymes of the MEP pathway through A-type proteins
(IscA, ErpA and SufA) in three different conditions (aerobic,
anaerobic and stress) [37]. A-type iron-sulfur carriers (ATCs) have
initially emerged in most bacteria before being acquired by
eukaryotes and a few archaea by means of horizontal gene transfer
[37]. Tan and co-workers have suggested that both IscA and SufA
are required for assembly of cubic Fe-S clusters in E. coli under
aerobic condition [69]. We further constructed possible bacterial
paths (aerobic and anaerobic) which are involved in transferring
Fe-S clusters to IspG and IspH in the yeast cytosol (Figure 5). Co-
transformation of erpA with either human ISCA1 or plant derived
CpIscA in addition to plant ispG and ispH and bacterial genes, fpr
and fldA did not result in a functional MEP pathway in both
aerobic and anaerobic conditions although human ISCA1 had
been shown to have partial cytosolic activity in HeLa cells [38]. S.
cerevisiae also contains two types of A-type carriers, Isa1 and Isa2,
which are localized in the mitochondrial matrix and in the
mitochondrial inter-membrane space, respectively [70,71]. The
mitochondrial localization is necessary for the functionality of both
the Isa1 and the Isa2 protein in yeast [70]. The contribution of
these proteins in the maturation process of IspG and IspH in an E.
coli strain which has a deficiency in erpA, iscA and sufA has been
demonstrated [37]. However, it has been demonstrated recently
that only Isa1 can be functionally replaced by the bacterial A-type
ISC proteins, ErpA, IscA and SufA [72].
In conclusion, we believe that specific physical interaction and
compartmentalization would be required for in vivo biogenesis and
transfer of essential prosthetic groups, here the iron-sulfur clusters
for activation of bacterial MEP pathway enzymes in yeast.
Therefore, it seems interesting to evaluate IspG and IspH
expression in the mitochondria as this may represent a new
interesting engineering strategy, which may even be relevant for
activation of other bacterial iron-sulfur cluster proteins in yeast.
Materials and Methods
Strain and Plasmid Construction
Sequences of all E. coli MEP pathway genes including dxs
(AAC73523), dxr (AAC73284), ispD (AAC75789), ispE
(AAC74292), ispF (AAC75788), ispG (AAC75568), ispH
(AAC73140) and idi (AAC75927) were used to construct four
different integrative fragments (File S1), in which each gene was
placed behind a TEF1 or PGK1 promoter and in front of a CYC1
or ADH1 terminator, respectively (Figure 2). Gene sequences were
codon optimized for expression in S. cerevisiae and the four
fragments were synthesized by DNA2.0 (Menlo Park, CA, USA).
The sequences of the four fragments are presented in File S1.
The synthetic fragments were integrated into S. cerevisiae
CEN.PK 113-13D (MATa MAL2-8c SUC2 ura3-52) and CEN.PK
113-1C (MATa MAL2-8c SUC2 trp1-289 ura3-52 his3D1) (kindly
provided by P. Ko¨tter, University of Frankfurt, Germany)
chromosome XVI (sites YPRCD15 and YPRCt3) by using a
standard transformation procedure [73] and a bipartite gene
targeting strategy [23]. KanMX as a selectable marker was looped
out by methods described previously [74] and Kluyveromyces lactis
(K.l.)URA3 was looped out by selection on SD plates supplemented
with 30 mg L21 uracil and 750 mg L21 5-fluoroorotic acid (5-
FOA), respectively. The strains harboring all MEP genes will in
the following be referred to as SCISP06 and SCISP12 (Table 1).
The genes erpA, fldA and fpr were amplified by PCR using E. coli
DH5a genomic DNA as a template and primers listed in Table 2.
The NotI/SacI restricted fldA fragment and BamHI/XhoI restricted
fpr fragment were cloned into pSP-GM1, a derivative of pSP-G1
[24,75]. A PTDH3–erpA–TPGK1 cassette was constructed by fusion
PCR performed with Phusion high-fidelity DNA polymerase
(Finnzymes, Espoo, Finland) and primer pair PGK1T-MreI-rev/
TDH3-Kpn2I-fw, restricted by Kpn2I/MreI and cloned into pSP-
GM1 containing the fldA and fpr genes. This resulted in
construction of plasmid pISP08 (Figure 3B). pISP08 was
transformed into strain SCISP06 resulting in formation of strain
SCISP16 (Table 1).
Sequences of plant genes encoding IspG (AAN87171.1) and
IspH (AAO15446.1) from A. thaliana were synthesized by DNA2.0
(Menlo Park, CA, USA). The sequence of iscA from Homo sapiens,
hISCA (NP_112202.2) was synthesized by GenScript (Piscataway,
NJ, USA). The sequence of iscA from A. thaliana, CpIscA (Q9XIK3.2)
was used to construct the expression cassette, PTDH3–CpIscA–
TPGK1, and this cassette was synthesized by GenScript. All
synthetic genes were codon optimized for expression in S. cerevisiae.
The BamHI/XhoI restricted At-IspG fragment and NotI/SacI
restricted At-IspH fragment were cloned into pSP-GM3, a
derivative of the pSP-GM1 plasmid [75]. The PvuII restricted
fragment of pSP-GM1 including the TEF1-PGK1 promoter region
was cloned into PvuII restricted pESC-HIS (Startagene,La
Jolla,USA) to construct pSP-GM3. A truncated fragment of
hISCA1 encoding a protein without the mitochondrial signal
peptide was amplified by PCR using the synthetic hISCA1 as a
template and primers listed in Table 2. A PTDH3–hISCA1–TPGK1
cassette was constructed by fusion PCR performed with Phusion
high-fidelity DNA polymerase (Finnzymes, Espoo, Finland) and
primer pair PGK1T-MreI-rev/TDH3-Kpn2I-fw. Both Kpn2I/
MreI restricted PTDH3–hISCA1–TPGK1 and PTDH3–CpIscA–TPGK1
fragments were cloned into pSP-GM3 containing the At-IspG and
At-IspH genes, respectively, resulting in pISP24 and pISP25. In the
next step, pISP08 was co-transformed with either pISP24 or
pISP25 (Figure 3B) into strain SCISP12 resulting in generation of
strain SCISP31 and SCISP32, respectively. To create the control
strain, empty plasmids, pSP-GM1 and pSP-GM3, were cloned
into wild type (CEN.PK113-13D), SCISP06 and SCISP12
resulting in strains SCISP28, SCISP29 and SCISP30, respectively.
The strains used in this study are listed in Table 1.
In order to delete ERG13, upstream and downstream flanking
regions of the target gene were PCR amplified. These upstream
and downstream flanking regions were fused to the 59 and the 39
part of the kanMX cassette amplified from plasmid pUG6 [74] by
fusion PCR performed with Phusion high-fidelity DNA polymer-
ase (Finnzymes). In the next step, the fused PCR fragments 1 and 2
including upstream flanking region of ERG13+ loxP - 2/3 kanMX
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Table 2. List of oligonucleotide primers used in this study.
Primer name Sequence
Oligonucleotide primers for verification of gene integration and transcription
DXS up ATGTCCTTTGATATTGCTAAATATCC
DXS down TAGGCCAACCAAGCCTTTATC
DXR up TGAAGCAGCTAACTATCTTGGGT
DXR down TCGTTAAGAAGCTAGTCTCATAACTTC
ispD up CACGACACACTTAGATGTGTGTG
ispD down TCAAGTGTTTTCTTGGTGGATG
ispE up ATGAGAACTCAATGGCCTTCC
ispE down ATAACATTGCCCTATGAAGAGG
ispF up ATGAGAATAGGTCACGGTTTCG
ispF down TTCGTAGCCTTGATTAGCAATG
ispG up CACAACCAAGCCCCAATACA
ispG down TCATTTCTCCACCTGTTGGAC
ispH up TGCAAATATTATTGGCGAATCC
ispH down TCAATCGACCTCACGTATATCC
idi up ATGCAGACTGAACACGTTATTCTG
idi down TTAATTGGGTGAATGCTGACAG
URA up GATGATGTAGTTTCTGGTTTTTAAATC
URA down TTTAGCTTTGACATGATTAAGCTCA
KanMx up TAGGTCTAGAGATCTGTTTAGCTTGC
KanMx down ATTAAGGGTTCTCGAGAGCTCG
Oligonucleotide primers for gene deletions
KanMx-1-fw CTGAAGCTTCGTACGCTG
KanMx-1-rev TCACCATGAGTGACGACTGA
KanMx-2-fw TTCCAACATGGATGCTGAT
KanMx-2-rev CTAGTGGATCTGATATCAC
ERG13-1-fw GTTGGTGTGGTATTAAAGGA
ERG13-1-rev CAGCGTACGAAGCTTCAGGGACTTGTCAATCAGAGTT
ERG13-2-fw GTGATATCAGATCCACTAGCAACCTGTAAATTGGTCAC
ERG13-2-rev CGTAAGATCTTCTAAATTTGTC
Oligonucleotide primers for verification of gene deletions
ERG13-up-fw TACGAGTGTGTTGAAAGTAG
ERG13-down-rev CATTTATGAAGGGGGTTCAG
Oligonucleotide primers for amplification of the bacterial genes
fpr-BamHI-fw GTTGTTGGATCCCAGGAGAAAAACATGGCTGA
fpr -XhoI-rev GTTGTTCTCGAG CGTTTATCGATAAGTAACCGCT
fldA-Not1-fw GTTGTTGCGGCCGCGAGGTTATTTCACTCATGGCT
fldA-SacI-rev GTTGTTGAGCTCCATCACATCAGGCATTGAGA
ErpA -fw ATGAGTGATGACGTAGCACT
ErpA-rev TTAGATACTAAAGGAAGAACCGCA
PGK1T-fus-fw (erpA) TGCGGTTCTTCCTTTAGTATCTAAGGTGTTGCTTTCTTATCCGA
PGK1T-MreI-rev GTTGTTCGCCGGCGGGTCGCAGAATTTTCGAGTT
TDH3-Kpn2I-fw GTTGTTTCCGGACAGTTTATCATTATCAATACTCGCC
TDH3-fus-rev (erpA) AGTGCTACGTCATCACTCATGAATCCGTCGAAACTAAGTTCTGGTG
Oligonucleotide primers for amplification of the human gene
hisca-fw ATGGCCGCCTTGACCTTGACT
hiscA-rev TCAGATGTTGAAGGATTCACCG
PGK1T-fus-fw (iscA) CGGTGAATCCTTCAACATCTGAGGTGTTGCTTTCTTATCCGA
TDH3-fus-rev (iscA) AGTCAAGGTCAAGGCGGCCATGAATCCGTCGAAACTAAGTTCTGGTG
Underlined characters correspond to flanking sequences used for fusion PCR; bold characters correspond to restriction sites.
doi:10.1371/journal.pone.0052498.t002
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and 2/3 kanMX - loxP+downstream flanking region of ERG13,
respectively, were used for deletion by bipartite gene targeting
[23]. Deletion of ERG13 was verified by diagnostic PCR. For this
purpose, PCR primers were designed to bind 400 to 500 bp up-
and downstream of the start and stop codon, respectively (Table 2).
All PCR products were sequenced.
Media Composition
The transformants were selected on minimal medium plates
containing 1.7 g L21 yeast nitrogen base w/o amino acids and
ammonium sulfate (Formedium, Hunstanton, England), 5 g L21
ammonium sulfate, 0.77 g L21 complete supplement mixture
(CSM w/o uracil or CSM w/o uracil and histidine) (MP
Biomedicals, Solon, OH, USA), 20 g L21 glucose and 20 g L21
agar. In media containing G418, 0.86 g L21 L-glutamic acid
monosodium salt monohydrate was used instead of ammonium
sulfate. Filter sterilized G418 disulfide salt (Sigma-Aldrich, St.
Louis, MO) was added to the media before plating to a final
concentration of 200 mg L21. Mevalonic acid lactone (Sigma-
Aldrich) was prepared as a 500 mg L21 stock solution in
2 N NaOH, incubated at 37uC for 30 min, filter sterilized, and
then added to the media to reach a final concentration of
10 mg L21. For anaerobic cultivations 125 mL ergosterol was
added to the media from a stock solution (1 g L21) that was
prepared as described previously [76]. Lovastatin (Sigma) was
hydrolyzed in ethanolic sodium hydroxide (15% (v/v) ethanol,
0.25% (w/v) NaOH) at 60uC for 1 h. After cooling down to room
temperature, it was added to shake flasks at a final concentration
of 2 g L21.
Batch Cultivation
Cotton-stopped, 50 mL Erlenmeyer flasks were used for
evaluation of the MEP pathway functionality using lovastatin.
The shake flasks contained 10 mL medium with the above
mentioned composition. 50 mL falcon tubes containing 5 mL
medium were used for seed cultures. Both seed tubes and shake
flasks were incubated at 30uC and agitated in an orbital shaker at
180 rpm. Pre-cultures were used to inoculate the shake flasks to a
final dry weight of 1 mg L21. Cell growth was monitored by
measuring the optical density at 600 nm using a Genesis20
spectrophotometer (Thermo Scientific, Madison, WI, USA). All
cultivations were performed in triplicate.
Supporting Information
File S1 File represents DNA sequences of the four
synthetic fragments which are carrying eight codon
optimized bacterial genes for expression in S. cerevi-
siae. For more information see text.
(PDF)
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